# Trade Mark Journal No.2026/029 17 July 2026

## UK00004411141 3 July 2026 (42)

WAIVE BY LSD

International priority date claimed: 24 February 2026 (Canada) (2458015)

Class 42
  Software as a service (SaaS) featuring non-downloadable, cloud-based software for facilitating structured stakeholder engagement and advisory programs for strategic planning and brand development within the pharmaceutical and life sciences industry, namely enabling communication, feedback collection, and moderated discussion between pharmaceutical organizations and healthcare professionals, patients, caregivers, and other healthcare stakeholders; providing tools for structured data collection, reporting, and artificial intelligence-assisted analysis and summarization of engagement feedback in support of stakeholder engagement strategy and advisory initiatives in the life sciences sector.

LSD The Agency Inc.

Representative: Sheridans Solicitors LLP